Clin2
NCT07206472Possibly a fitRecruiting

Study of bempedoic acid for high cholesterol

Primary HypercholesterolaemiaMixed Dyslipidemia

Part of Heart & circulation, Hormones & metabolism clinical trials.

This study observes patients with high cholesterol or mixed lipid disorders who are taking bempedoic acid, alone or with ezetimibe, to see how it works in real life. It aims to gather information that may help doctors better manage cholesterol.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,120 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have high cholesterol or a mixed lipid disorder.
  • Your doctor has prescribed or plans to prescribe bempedoic acid or the combination pill.
  • If you already take this medicine, you started within the last 3 months.
  • You do not have any conditions that make this medicine unsafe for you.
  • You are not taking part in another clinical trial that tests a treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06686615Recruiting
Study of a triple cholesterol medicine combination in high-risk patients

This study tests a cholesterol-lowering combination of three medicines: bempedoic acid, ezetimibe, and a statin (atorvastatin or rosuvastatin). It is for people with high cholesterol, especially those at high risk for heart problems, who need stronger treatment.

Braunau am Inn
NCT07614958Recruiting· Phase 3
Testing a new cholesterol medicine against bempedoic acid

This study compares two new medicines—obicetrapib and bempedoic acid—to see which one better lowers cholesterol in people whose cholesterol remains high despite taking standard medications. If your cholesterol isn't controlled well enough with current drugs, this trial may help you access an experimental treatment.

Stockton-on-Tees
NCT07474649Not yet recruiting· Phase 3
Study of a cholesterol-lowering combination pill for patients without heart events

This trial tests a triple therapy pill (bempedoic acid, ezetimibe, and a high-intensity statin) in patients who have extensive plaque in their heart arteries but have never had a heart attack or stroke. It aims to see if this combination can further lower cholesterol and prevent future problems.

Berlin
NCT06314919Recruiting
Study of a combination pill for high cholesterol

This study tests a single pill that combines two cholesterol-lowering medicines (pitavastatin and ezetimibe). It may be a good fit if you already take a statin or a statin plus ezetimibe and your doctor wants to adjust your treatment.

Seoul
NCT06646354Enrolling by invitation· Phase 3
Study of two experimental drugs for high blood pressure and cholesterol

This trial tests whether taking two experimental drugs together can safely lower both high blood pressure and high cholesterol. It may be an option if you have both conditions and your blood pressure is not extremely high.

Seoul
NCT06780410Recruiting· Phase 3
Study of bempedoic acid for lowering cholesterol

This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.

Beijing

Hear when a new Mixed Dyslipidemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.